Effects of purified poloxamer 407 gel on vascular occlusion and the coronary endothelium

European Journal of Cardio-thoracic Surgery : Official Journal of the European Association for Cardio-thoracic Surgery
Munir BoodhwaniFrank W Sellke

Abstract

Vascular occlusion during off-pump coronary surgery often results in sub-optimal visualization and endothelial damage of the target vessel. We have previously reported the safety of purified poloxamer 407, a gel with reverse thermosensitive properties, in a model of off-pump coronary occlusion. The aim of this study was to evaluate different gel concentrations and their effects on coronary occlusion time, myocardial contractility, endothelial function, and markers of myocardial injury and apoptosis. Yorkshire swine (30-35 kg) underwent sternotomy and mid-LAD occlusion using either microvascular clamps (n=6) or varying quantities of three different concentrations (20%; n=6, 22.5%; n=3, and 25%; n=3) of purified poloxamer 407 gel. Distal LAD flow, left ventricular pressure, and in vitro microvascular reactivity were assessed. Molecular markers of myocardial injury and apoptosis were assessed using Western blotting. Duration of ischemia correlated significantly with the amount of injected gel for the 20% and 22.5% formulations (Spearman r=0.64, p=0.02 and r=0.85, p=0.03, respectively) but not for the 25% gel (r=0.22, p=0.66). There were no significant differences in LV contractility (maximum+dp/dt) (p=0.86) as well as LAD flow (p=...Continue Reading

Citations

Feb 19, 2013·General Thoracic and Cardiovascular Surgery·Fadhil Al-Amran, Hayder M Abdulnabi
Oct 15, 2010·Archives of Pharmacal Research·Jaepyoung ChoEuichaul Oh
Jan 24, 2013·Journal of Cardiothoracic Surgery·Arif GucuAhmet Ozyazicioglu
Aug 26, 2015·Journal of Investigative Surgery : the Official Journal of the Academy of Surgical Research·Peng-Fei WangJia-Hong Dong
Aug 25, 2012·The Annals of Thoracic Surgery·Munir Boodhwani
Aug 10, 2011·Journal of Plastic, Reconstructive & Aesthetic Surgery : JPRAS·G A GiesslerA B Schmidt
Dec 6, 2011·Urology·Niall J HartyPeter N Madras
Jan 10, 2012·HPB : the Official Journal of the International Hepato Pancreato Biliary Association·James J PomposelliPeter N Madras
May 25, 2010·The Annals of Thoracic Surgery·Olivier BouchotRoger Brenot
Mar 24, 2010·Journal of Vascular and Interventional Radiology : JVIR·Sebastian FlackePeter N Madras
Oct 27, 2015·The Journal of Surgical Research·Jianpeng LiYi Lv
Jan 21, 2009·Gastrointestinal Endoscopy·Gloria Fernández-EsparrachChristopher C Thompson
Nov 26, 2011·The Annals of Thoracic Surgery·Bernhard WinklerFriedrich S Eckstein
Nov 8, 2012·European Journal of Vascular and Endovascular Surgery : the Official Journal of the European Society for Vascular Surgery·V Decrouy-DuruzF Saucy
Jun 12, 2013·Journal of Controlled Release : Official Journal of the Controlled Release Society·Islam HamadS Moein Moghimi
Jul 1, 2007·Innovations : Technology and Techniques in Cardiothoracic and Vascular Surgery·Arnaud MommerotLouis P Perrault
Jun 7, 2019·Advanced Materials·Jingjie HuRahmi Oklu

❮ Previous
Next ❯

Related Concepts

Related Feeds

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis

Cardiomyopathy

Cardiomyopathy is a disease of the heart muscle, that can lead to muscular or electrical dysfunction of the heart. It is often an irreversible disease that is associated with a poor prognosis. There are different causes and classifications of cardiomyopathies. Here are the latest discoveries pertaining to this disease.